BRUNSWICK CORP (BC) Fundamental Analysis & Valuation

NYSE:BC • US1170431092

Current stock price

76.01 USD
-3.34 (-4.21%)
Last:

This BC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BC Profitability Analysis

1.1 Basic Checks

  • BC had positive earnings in the past year.
  • In the past year BC had a positive cash flow from operations.
  • Of the past 5 years BC 4 years were profitable.
  • In the past 5 years BC always reported a positive cash flow from operatings.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • BC has a Return On Assets of -2.58%. This is comparable to the rest of the industry: BC outperforms 41.94% of its industry peers.
  • With a Return On Equity value of -8.45%, BC is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
  • With a decent Return On Invested Capital value of 5.91%, BC is doing good in the industry, outperforming 64.52% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BC is in line with the industry average of 7.55%.
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROIC 5.91%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • BC's Operating Margin of 5.83% is fine compared to the rest of the industry. BC outperforms 74.19% of its industry peers.
  • BC's Operating Margin has declined in the last couple of years.
  • BC's Gross Margin of 24.84% is on the low side compared to the rest of the industry. BC is outperformed by 61.29% of its industry peers.
  • In the last couple of years the Gross Margin of BC has declined.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 24.84%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

4

2. BC Health Analysis

2.1 Basic Checks

  • BC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, BC has less shares outstanding
  • The number of shares outstanding for BC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BC has an improved debt to assets ratio.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • BC has an Altman-Z score of 3.07. This indicates that BC is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.07, BC is doing good in the industry, outperforming 64.52% of the companies in the same industry.
  • BC has a debt to FCF ratio of 5.30. This is a neutral value as BC would need 5.30 years to pay back of all of its debts.
  • BC has a Debt to FCF ratio (5.30) which is in line with its industry peers.
  • BC has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.11, BC is doing worse than 70.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Altman-Z 3.07
ROIC/WACC0.59
WACC9.93%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that BC should not have too much problems paying its short term obligations.
  • BC has a worse Current ratio (1.44) than 61.29% of its industry peers.
  • A Quick Ratio of 0.61 indicates that BC may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.61, BC is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.61
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. BC Growth Analysis

3.1 Past

  • The earnings per share for BC have decreased strongly by -28.29% in the last year.
  • The Earnings Per Share has been decreasing by -8.40% on average over the past years.
  • BC shows a small growth in Revenue. In the last year, the Revenue has grown by 2.40%.
  • BC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%

3.2 Future

  • Based on estimates for the next years, BC will show a very strong growth in Earnings Per Share. The EPS will grow by 27.86% on average per year.
  • Based on estimates for the next years, BC will show a small growth in Revenue. The Revenue will grow by 5.76% on average per year.
EPS Next Y34.17%
EPS Next 2Y28.38%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue Next Year9.16%
Revenue Next 2Y7.11%
Revenue Next 3Y6.77%
Revenue Next 5Y5.76%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

5

4. BC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.24, BC is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 64.52% of the companies listed in the same industry.
  • BC's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.54.
  • The Price/Forward Earnings ratio is 17.32, which indicates a rather expensive current valuation of BC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 64.52% of the companies listed in the same industry.
  • BC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.68.
Industry RankSector Rank
PE 23.24
Fwd PE 17.32
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 67.74% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 70.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.49
EV/EBITDA 11.59
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • BC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BC's earnings are expected to grow with 27.67% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y28.38%
EPS Next 3Y27.67%

6

5. BC Dividend Analysis

5.1 Amount

  • BC has a Yearly Dividend Yield of 2.20%.
  • BC's Dividend Yield is a higher than the industry average which is at 1.19.
  • Compared to an average S&P500 Dividend Yield of 1.82, BC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.2%

5.2 History

  • On average, the dividend of BC grows each year by 11.59%, which is quite nice.
  • BC has paid a dividend for at least 10 years, which is a reliable track record.
  • BC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.59%
Div Incr Years13
Div Non Decr Years17
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • The earnings of BC are negative and hence is the payout ratio. BC will probably not be able to sustain this dividend level.
  • BC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-82.01%
EPS Next 2Y28.38%
EPS Next 3Y27.67%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

BC Fundamentals: All Metrics, Ratios and Statistics

BRUNSWICK CORP

NYSE:BC (4/30/2026, 10:57:04 AM)

76.01

-3.34 (-4.21%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Industry Strength42.24
Industry Growth67.08
Earnings (Last)04-30
Earnings (Next)N/A
Inst Owners104.42%
Inst Owner Change-0.25%
Ins Owners1.01%
Ins Owner Change0.11%
Market Cap4.95B
Revenue(TTM)5.36B
Net Income(TTM)-137.30M
Analysts77.14
Price Target92.13 (21.21%)
Short Float %6.41%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield 2.2%
Yearly Dividend1.72
Dividend Growth(5Y)11.59%
DP-82.01%
Div Incr Years13
Div Non Decr Years17
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-2.34%
Max EPS beat(2)10.64%
EPS beat(4)3
Avg EPS beat(4)41.04%
Min EPS beat(4)-2.34%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)19.7%
EPS beat(12)5
Avg EPS beat(12)11.6%
EPS beat(16)7
Avg EPS beat(16)8.89%
Revenue beat(2)2
Avg Revenue beat(2)5.84%
Min Revenue beat(2)4.71%
Max Revenue beat(2)6.96%
Revenue beat(4)4
Avg Revenue beat(4)7.35%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)5
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-1.2%
PT rev (1m)2.08%
PT rev (3m)11.82%
EPS NQ rev (1m)-3.31%
EPS NQ rev (3m)-41.32%
EPS NY rev (1m)0.46%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)3.24%
Valuation
Industry RankSector Rank
PE 23.24
Fwd PE 17.32
P/S 0.92
P/FCF 12.49
P/OCF 8.8
P/B 3.04
P/tB 55.23
EV/EBITDA 11.59
EPS(TTM)3.27
EY4.3%
EPS(NY)4.39
Fwd EY5.77%
FCF(TTM)6.09
FCFY8.01%
OCF(TTM)8.63
OCFY11.36%
SpS82.37
BVpS24.97
TBVpS1.38
PEG (NY)0.68
PEG (5Y)N/A
Graham Number42.8596 (-43.61%)
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROCE 8.04%
ROIC 5.91%
ROICexc 6.33%
ROICexgc 10.98%
OM 5.83%
PM (TTM) N/A
GM 24.84%
FCFM 7.39%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
ROICexc(3y)9.5%
ROICexc(5y)12.37%
ROICexgc(3y)18.05%
ROICexgc(5y)24.22%
ROCE(3y)11.84%
ROCE(5y)15.22%
ROICexgc growth 3Y-29.65%
ROICexgc growth 5Y-20.68%
ROICexc growth 3Y-27.91%
ROICexc growth 5Y-19.68%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Debt/EBITDA 2.99
Cap/Depr 56.68%
Cap/Sales 3.09%
Interest Coverage 2.72
Cash Conversion 92.92%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.61
Altman-Z 3.07
F-Score5
WACC9.93%
ROIC/WACC0.59
Cap/Depr(3y)73.55%
Cap/Depr(5y)107.72%
Cap/Sales(3y)3.6%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
EPS Next Y34.17%
EPS Next 2Y28.38%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%
Revenue Next Year9.16%
Revenue Next 2Y7.11%
Revenue Next 3Y6.77%
Revenue Next 5Y5.76%
EBIT growth 1Y-27.9%
EBIT growth 3Y-31.52%
EBIT growth 5Y-10.54%
EBIT Next Year85.06%
EBIT Next 3Y32.29%
EBIT Next 5Y23.77%
FCF growth 1Y50.11%
FCF growth 3Y26.07%
FCF growth 5Y-8.44%
OCF growth 1Y30.3%
OCF growth 3Y-1.38%
OCF growth 5Y-6.78%

BRUNSWICK CORP / BC Fundamental Analysis FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status of BRUNSWICK CORP (BC) stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


Can you provide the profitability details for BRUNSWICK CORP?

BRUNSWICK CORP (BC) has a profitability rating of 3 / 10.


What is the expected EPS growth for BRUNSWICK CORP (BC) stock?

The Earnings per Share (EPS) of BRUNSWICK CORP (BC) is expected to grow by 34.17% in the next year.


Is the dividend of BRUNSWICK CORP sustainable?

The dividend rating of BRUNSWICK CORP (BC) is 6 / 10 and the dividend payout ratio is -82.01%.